First Enbrel Biosimilar Recommended for Approval in EuropeFirst Enbrel Biosimilar Recommended for Approval in Europe
The EMA has recommended Benepali, an etanercept biosimilar for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis. International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news
More News: Arthritis | Enbrel | Health | Psoriasis | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology